These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18515902)

  • 21. Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender.
    Dekker N; Meijer J; Koeter M; van den Brink W; van Beveren N; Kahn RS; Linszen DH; van Os J; Wiersma D; Bruggeman R; Cahn W; de Haan L; Krabbendam L; Myin-Germeys I;
    Psychol Med; 2012 Sep; 42(9):1903-11. PubMed ID: 22452790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neuropsychological profiles of young psychosis patients with and without current cannabis use.
    Bogaty SER; Crouse JJ; Hickie IB; Hermens DF
    Cogn Neuropsychiatry; 2019 Jan; 24(1):40-53. PubMed ID: 30621505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study.
    van der Meer FJ; Velthorst E;
    Psychol Med; 2015 Jul; 45(9):1977-88. PubMed ID: 25654244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is cannabis use a contributory cause of psychosis?
    Degenhardt L; Hall W
    Can J Psychiatry; 2006 Aug; 51(9):556-65. PubMed ID: 17007222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis use in early adolescence is associated with higher negative schizotypy in females.
    Albertella L; Le Pelley ME; Copeland J
    Eur Psychiatry; 2017 Sep; 45():235-241. PubMed ID: 28957793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoids and psychosis.
    Sewell RA; Ranganathan M; D'Souza DC
    Int Rev Psychiatry; 2009 Apr; 21(2):152-62. PubMed ID: 19367509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Premorbid cannabis use is associated with more symptoms and poorer functioning in schizophrenia spectrum disorder.
    Ringen PA; Nesvåg R; Helle S; Lagerberg TV; Lange EH; Løberg EM; Agartz I; Andreassen OA; Melle I
    Psychol Med; 2016 Nov; 46(15):3127-3136. PubMed ID: 27534999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological, neurobiological, and genetic clues to the mechanisms linking cannabis use to risk for nonaffective psychosis.
    van Winkel R; Kuepper R
    Annu Rev Clin Psychol; 2014; 10():767-91. PubMed ID: 24471373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Change in cannabis use in the general population: a longitudinal study on the impact on psychotic experiences.
    van Gastel WA; Vreeker A; Schubart CD; MacCabe JH; Kahn RS; Boks MP
    Schizophr Res; 2014 Aug; 157(1-3):266-70. PubMed ID: 24930951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabis Use, Polysubstance Use, and Psychosis Spectrum Symptoms in a Community-Based Sample of U.S. Youth.
    Jones JD; Calkins ME; Scott JC; Bach EC; Gur RE
    J Adolesc Health; 2017 Jun; 60(6):653-659. PubMed ID: 28318911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tests of causal linkages between cannabis use and psychotic symptoms.
    Fergusson DM; Horwood LJ; Ridder EM
    Addiction; 2005 Mar; 100(3):354-66. PubMed ID: 15733249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adolescent bullying, cannabis use and emerging psychotic experiences: a longitudinal general population study.
    Mackie CJ; O'Leary-Barrett M; Al-Khudhairy N; Castellanos-Ryan N; Struve M; Topper L; Conrod P
    Psychol Med; 2013 May; 43(5):1033-44. PubMed ID: 23171473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study.
    Schoeler T; Petros N; Di Forti M; Klamerus E; Foglia E; Ajnakina O; Gayer-Anderson C; Colizzi M; Quattrone D; Behlke I; Shetty S; McGuire P; David AS; Murray R; Bhattacharyya S
    Lancet Psychiatry; 2016 Oct; 3(10):947-953. PubMed ID: 27567467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia.
    Leeson VC; Harrison I; Ron MA; Barnes TR; Joyce EM
    Schizophr Bull; 2012 Jun; 38(4):873-80. PubMed ID: 21389110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reasons for cannabis use in men with and without psychosis.
    Green B; Kavanagh DJ; Young RM
    Drug Alcohol Rev; 2004 Dec; 23(4):445-53. PubMed ID: 15763749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis.
    Dragt S; Nieman DH; Schultze-Lutter F; van der Meer F; Becker H; de Haan L; Dingemans PM; Birchwood M; Patterson P; Salokangas RK; Heinimaa M; Heinz A; Juckel G; Graf von Reventlow H; French P; Stevens H; Ruhrmann S; Klosterkötter J; Linszen DH;
    Acta Psychiatr Scand; 2012 Jan; 125(1):45-53. PubMed ID: 21883099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cannabis-induced mania? A case study and literature review].
    Matthijs N; Touquet G; De Hert M
    Tijdschr Psychiatr; 2009; 51(11):859-63. PubMed ID: 19904712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis.
    Buchy L; Cannon TD; Anticevic A; Lyngberg K; Cadenhead KS; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
    BMC Psychiatry; 2015 Nov; 15():276. PubMed ID: 26553191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis.
    Schoeler T; Monk A; Sami MB; Klamerus E; Foglia E; Brown R; Camuri G; Altamura AC; Murray R; Bhattacharyya S
    Lancet Psychiatry; 2016 Mar; 3(3):215-25. PubMed ID: 26777297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabis and psychosis: have we found the missing links?
    Parakh P; Basu D
    Asian J Psychiatr; 2013 Aug; 6(4):281-7. PubMed ID: 23810133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.